Vitiligo, alopecia areata may up atopic dermatitis risk

Vitiligo, alopecia areata may up atopic dermatitis risk
The prevalence of atopic dermatitis is higher among patients with vitiligo or alopecia areata, according to research published online Dec. 3 in JAMA Dermatology.

(HealthDay)—The prevalence of atopic dermatitis (AD) is higher among patients with vitiligo or alopecia areata (AA), according to research published online Dec. 3 in JAMA Dermatology.

Girish C. Mohan, M.D., and Jonathan I. Silverberg, M.D., Ph.D., M.P.H., of the Northwestern University Feinberg School of Medicine in Chicago, conducted a of the literature and performed a meta-analysis of data from 33 observational studies. The authors sought to assess the prevalence of AD among patients with and without either vitiligo or AA.

The researchers found that pooled analysis showed significantly increased risk of AD in patients with vitiligo (odds ratio [OR], 7.82; P < 0.001) or AA (OR, 2.57; P < 0.001). Pooled analysis of data from three studies showed greater risk of AD among patients with early-onset vitiligo (less than 12 years) rather than late-onset vitiligo (OR, 3.54; P < 0.001). Pooled analysis of data from four studies showed greater risk of AD among with alopecia totalis or alopecia universalis rather than patchy alopecia (OR, 1.22; P = 0.04).

"Patients with either vitiligo, especially early-onset disease, or AA, especially alopecia totalis or alopecia universalis, have significantly increased risk for AD," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

Journal information: JAMA Dermatology

Copyright © 2014 HealthDay. All rights reserved.

Citation: Vitiligo, alopecia areata may up atopic dermatitis risk (2014, December 5) retrieved 25 April 2024 from https://medicalxpress.com/news/2014-12-vitiligo-alopecia-areata-atopic-dermatitis.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Study examines vitiligo, alopecia areata and chronic graft vs. host disease

 shares

Feedback to editors